Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation

Sponsor
Chang Gung Memorial Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05903235
Collaborator
(none)
45
1
3
35
1.3

Study Details

Study Description

Brief Summary

The specific study aims will be:
  1. To design and develop the hardware and software of the VR+MT and MR+MT systems.

  2. To test the feasibility of the VR+MT and MR+MT systems from the patients and to collect the feedback of users with respect to their experiences.

  3. To examine the treatment effects of VR+MT and MR+MT compared to the traditional MT (i.e., control group) in patients with stroke by conducting a randomized controlled trial.

  4. To identify who will be the possible good responders to VR+MT and MR+MT based on their baseline motor functions and mental imagery abilities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Virtual Reality-based Mirror Therapy (VR+MT)
  • Behavioral: Mixed Reality-based Mirror Therapy (MR+MT)
  • Behavioral: Traditional Mirror Therapy (MT)
N/A

Detailed Description

Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems & Feasibility Study

Sixteen patients with stroke will be recruited in this phase Ⅰ study. During the pilot testing, each stroke patient will use each of the VR+MT and MR+MT systems with the assistance of a researcher holding the occupational therapist certification. The order of the feasibility test of the 2 systems will be counterbalanced across the patients. At the end of the feasibility study of each system, the patients will be asked to complete the System Usability Scale, Virtual Reality Sickness Questionnaire, and a self-designed questionnaire to assess the user experience and perspective about these new systems and their view of its suitability for stroke patients.

Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy

This three-arm, single-blind, randomized controlled trial will investigate the treatment effects among the 3 groups of VR+MT, MR+MT, and traditional MT. An estimated 45 patients with stroke will be recruited to participate in this phase Ⅱ study. Each participant will receive a total of 15 training sessions (40 minutes per session) within 5 weeks. Clinical outcome measures will be conducted at baseline, at immediately after treatment, and at 1 month follow-up after treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Technology-based and Activity-based Design of Mirror Therapy Principles: Two Mixed Reality and Virtual Reality Mirrored-hand Systems for Stroke Rehabilitation
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2026
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Reality-based Mirror Therapy (VR+MT)

In each therapy session, the patients will execute 2 upper-limb functional tasks, starting with easy then more complex tasks.

Behavioral: Virtual Reality-based Mirror Therapy (VR+MT)
In this VR+MT group, the patients will be instructed to perform the unilateral movements of the non-affected upper limb simultaneously while observing the animated hand as mirroring reflection of the affected hand within the immersive environment, which presented on the goggle via the VR+MT system.

Experimental: Mixed Reality-based Mirror Therapy (MR+MT)

The patients will execute 2 upper-limb functional tasks in each session.

Behavioral: Mixed Reality-based Mirror Therapy (MR+MT)
In the MR+MT group, the patients will be instructed to perform the unilateral movements of the non-affected upper limb concurrently meanwhile watching the real-time mirroring image reflection of the non-affected upper limb's movements of the patients captured, transformed, and superimposed on the affected upper limb, which projected to the screen from the front side via the MR+MT system.

Active Comparator: Traditional Mirror Therapy (MT)

The patients will execute 2 to 3 categories of activities per training session: (1) active range of motion exercises, (2) reaching movement or object manipulation, and (3) upper-limb functional tasks.

Behavioral: Traditional Mirror Therapy (MT)
In the traditional MT group, patients will be instructed to perform the unilateral movements of the non-affected upper limb at the same time while watching the mirror of a mirror box placed in front of the patient's midsagittal plane, in which the illusory reflection of the non-affected upper limb appears as if it were the another affected upper limb.

Outcome Measures

Primary Outcome Measures

  1. Change scores of Fugl-Meyer Assessment of the Upper Extremity [baseline, 5 weeks, 9 weeks]

    The Fugl-Meyer Assessment of the Upper Extremity is a measure with sound psychometric properties to evaluate upper-limb hemiparesis of patients following stroke.

  2. Change scores of Nottingham Extended Activities of Daily Living scale [baseline, 5 weeks, 9 weeks]

    The Nottingham Extended Activities of Daily Living scale is an ease-of-use measure with sound reliability and validity to assess independence of more complex daily function.

Secondary Outcome Measures

  1. Change scores of grip strengths [baseline, 5 weeks, 9 weeks]

    The Jamar® Plus+ Digital Hand Dynamometer has been designed similarly to the reliable and validated Jamar Hydraulic Hand Dynamometer to measure the grip strength. The grip strengths of both hands were alternatively measured in kilograms (kg) by adopting the average of three measurements.

  2. Change scores of lateral pinch strengths [baseline, 5 weeks, 9 weeks]

    The Jamar® Plus+ Digital Pinch Gauge has been developed and widely used with the advantages of an easy-to-read digital readout and being capable of storing data. The lateral pinch strengths of both hands will be alternatively measured in kilograms (kg) by adopting the average of three measurements.

  3. Change scores of palmar pinch strengths [baseline, 5 weeks, 9 weeks]

    The Jamar® Plus+ Digital Pinch Gauge has been developed and widely used with the advantages of an easy-to-read digital readout and being capable of storing data. The palmar pinch strengths of both hands will be alternatively measured in kilograms (kg) by adopting the average of three measurements.

  4. Change scores of Box and Block Test [baseline, 5 weeks, 9 weeks]

    The Box and Block Test is a tool with sound reliability and validity to evaluate hand dexterity.

  5. Change scores of Revised Nottingham Sensory Assessment [baseline, 5 weeks, 9 weeks]

    The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to evaluate sensory function of patients following stroke.

  6. Change scores of Chedoke Arm and Hand Activity Inventory [baseline, 5 weeks, 9 weeks]

    The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to evaluate the independence of patients following stroke to perform activities of daily living with an affected upper limb.

  7. Change scores of the health state of EQ-5D-5L [baseline, 5 weeks, 9 weeks]

    The questionnaire of EQ-5D-5L comprises 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5-dimension questionnaire represents the health state.

  8. Change scores of the visual analogue scale of EQ-5D-5L [baseline, 5 weeks, 9 weeks]

    The visual analogue scale of EQ-5D-5L score will be scored from 0 to 100. A higher score indicates better overall current health.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Phase Ⅰ: Design and Development of the VR+MT and MR+MT Systems & Feasibility Study

Inclusion Criteria:
  • diagnosed with unilateral stroke

  • age of 20 to 80 years

  • a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60

  • able to follow the study instructions and provide the feedback of user experiences verbally

Exclusion Criteria:
  • diagnosed with global or receptive aphasia

  • the presence of severe neglect

  • the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception

Phase Ⅱ: Validation and Comparison of Clinical Treatment Efficacy

Inclusion Criteria:
  • diagnosed with unilateral stroke

  • more than 6 months after stroke onset

  • age of 20 to 80 years

  • a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60

  • able to follow the study instructions

  • capable of participating in the assessment process and treatment program

Exclusion Criteria:
  • diagnosed with global or receptive aphasia

  • the presence of severe neglect

  • the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taoyuan Chang Gung Memorial Hospital Taoyuan City Taiwan 333

Sponsors and Collaborators

  • Chang Gung Memorial Hospital

Investigators

  • Principal Investigator: Yu-Wei Hsieh, PhD, Department of Occupational Therapy, College of Medicine, Chang Gung University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT05903235
Other Study ID Numbers:
  • 202201968A3
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chang Gung Memorial Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023